# CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

> **NCT03560752** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Accelerated Phase CML, BCR-ABL1 Positive
- Acute Lymphoblastic Leukemia in Remission
- Acute Myeloid Leukemia in Remission
- Chronic Lymphocytic Leukemia
- Chronic Phase CML, BCR-ABL1 Positive
- Cytomegalovirus Positive
- Donor
- Hematopoietic Cell Transplant Recipient
- Hodgkin Lymphoma
- Myelodysplastic Syndrome
- Myelodysplastic/Myeloproliferative Neoplasm
- Non-Hodgkin Lymphoma
- Myelofibrosis
- Hematopoietic and Lymphoid Cell Neoplasm

## Interventions

- **BIOLOGICAL:** Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

## Key facts

- **NCT ID:** NCT03560752
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-20
- **Primary completion:** 2022-01-22
- **Final completion:** 2026-07-29
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560752, "CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03560752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*